Vasa Denticity Ltd Q2 FY26 Results & Concall Highlights: Revenue ₹50 Cr
Published 16 Jul 2026 | Healthcare Equipment & Supplies | Market Cap: ₹673 Cr
Targeting ₹500–600 crore revenue by FY27, broadly on track with directional targets. The company targets revenue of ₹500–600 crore by FY27 and ₹800–1,200 crore by FY29, viewing these as directional aspirations rather than firm guidance.
From Vasa Denticity Ltd's Q2 FY26 earnings-call transcript · updated 23 Aug 2026.
Price
₹396
Market Cap
₹673 Cr
P/E Ratio
62.4
How does Vasa Denticity Ltd rank in Healthcare Equipment & Supplies?
Compare Vasa Denticity Ltd against every Healthcare Equipment & Supplies company this quarter on revenue, margins and earnings-call signals.
Vasa Denticity Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹72 Cr, net profit ₹1 Cr.
Full financials →📊 Revenue & Sales Performance
- →Targeting ₹500–600 crore revenue by FY27, broadly on track with directional targets.
- →Aspirational revenue range of ₹800–1,200 crore by FY29, though dependent on execution factors.
- →Growth levers include increasing active customers (e.g., from 60,000 to 100,000 monthly) and increasing wallet share per customer (e.g., from 15% to 40%).
- →Emphasis on deepening market penetration and wallet share rather than just short-term growth.
- →Smileworks lab is on a path to break-even with potential to exceed ₹50 crore revenue in the long term, though timeline is uncertain.
- →Delivery timeline improvements (targeting same-day in Tier I cities and average below 48 hours nationwide) aimed to support revenue growth.
- →Investments in inventory and warehouses intended to balance faster delivery and margin discipline while enabling scale.
- →Long-term vision includes building the dominant dental ecosystem in India with 5x to 10x scalability from current levels.
📈 Profitability & Margins
- →The company targets revenue of ₹500–600 crore by FY27 and ₹800–1,200 crore by FY29, viewing these as directional aspirations rather than firm guidance.
- →Growth is expected to be driven mainly by ARPU expansion and increased wallet share from existing and new customers.
- →Operating leverage is anticipated as tech and warehousing investments mature, with variable incremental costs lower than proportional order volume growth.
- →EBITDA margins currently compressed due to investments but expected to improve toward mid-teens over time as stability and efficiencies increase.
- →Focus on building a strong, defensible business without heavy cash burn aimed at sustainable, long-term profitability.
- →One-hour quarterly earnings calls initiated to provide continual updates and maintain transparency on growth and profitability progress.
🏗️ Capital Expenditure Plans
- →No major capex plans have been decided for FY27 as of now.
- →If any changes occur regarding capex, the company will communicate them appropriately.
- →Significant fixed-cost investments have already been made in warehousing during H1, enabling operating leverage going forward.
- →Tech investments have largely been completed with a revamped app and website; future upgrades will be continuous but not capital-intensive.
- →Investment focus remains on building service centres, with plans for own service centres in all Tier I cities within two years.
- →The company continues to assess strategic acquisitions (e.g., IDS Denmed) for long-term value but pursues only those adding genuine strategic value for dentists.
💰 Fundraising & Capital Structure
- →As of now, there are no major capex plans decided for FY27, implying no immediate large funding requirement.
- →The company did not mention any ongoing or planned new fundraising through debt or equity in the transcript.
- →They emphasize focusing on cash flow discipline, profitability, and gradual investments rather than heavy capital burn.
- →Any changes or new fundraising activities will be communicated appropriately in the future.
- →The management is committed to long-term value creation without depending on aggressive capital raising in the short term.
📋 Order Book & Pipeline
- →The transcript does not explicitly mention the current or expected order book or pending orders.
- →Focus is on improving delivery timelines, expanding product coverage, and strengthening service quality to convert more demand into revenue.
- →Current delivery time averages around 4 days; the company aspires to reduce this below 48 hours across Tier I cities.
- →The firm prioritizes having enough inventory to avoid stockouts, even if it leads to temporarily higher inventory days (currently expected to stabilize at 120–150 days).
- →Investments in warehouses and inventory imply readiness to handle growing order volumes.
- →The company is improving operational efficiencies and tech capacity to potentially handle 3x the current order volume.
- →No detailed numeric data on order backlog or pending orders is provided publicly in this transcript.
Key Metrics
Frequently Asked Questions
What were Vasa Denticity Ltd Q2 FY26 results?
Targeting ₹500–600 crore revenue by FY27, broadly on track with directional targets. The company targets revenue of ₹500–600 crore by FY27 and ₹800–1,200 crore by FY29, viewing these as directional aspirations rather than firm guidance.
What is Vasa Denticity Ltd share price analysis?
Vasa Denticity Ltd currently shows a neutral. The stock trades at a P/E of 62.4 with a market cap of ₹673 Cr. Investors should review the full earnings analysis for detailed insights.
Is Vasa Denticity Ltd planning capital expenditure?
No major capex plans have been decided for FY27 as of now.
Keep Vasa Denticity Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.